The ECLIA kit used in this study detects total antibodies (IgG, IgA, and IgM) against NP [17, 18]; however, our data indicated that a low titer of anti-SARS-CoV-2 antibody against NP contributed to the false-negative results in asymptomatic and mild COVID-19 patients. This evidence concerns the gene CD79A and COVID-19.